Literature DB >> 7635944

Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes.

C M Thaik1, A Calderone, N Takahashi, W S Colucci.   

Abstract

Mononuclear cell infiltration and local cytokine elaboration are hallmarks of inflammatory and immunologic heart diseases. To test the hypothesis that cytokines can modulate cardiac myocyte growth and phenotype, myocytes cultured from neonatal rat hearts were exposed to IL-1 beta, an inflammatory cytokine prevalent in myocardial inflammation. IL-1 beta (2 ng/ml, 24 h) increased [3H]leucine incorporation by 30 +/- 4% (P < 0.001, n = 29) and net cellular protein content by 20 +/- 4% (P < 0.001, n = 27), but had no effect on DNA synthesis. Northern hybridization showed that IL-1 beta increased prepro-atrial natriuretic factor (ANF) mRNA (5.8 +/- 1.5-fold, P < 0.01, n = 13) and beta-myosin heavy chain (beta-MHC) mRNA (> 10-fold, n = 4), and decreased mRNA levels for sarcoplasmic reticulum Ca(2+)-ATPase (SERCA2) (-46 +/- 7%; P < 0.001; n = 11), calcium release channel (CRC) (-65 +/- 11%, P < 0.001, n = 8) and voltage-dependent calcium channel (VDCC) (-53 +/- 7%, P < 0.001, n = 8). NG-monomethyl-L-arginine (1 mM), an inhibitor of nitric oxide (NO) synthesis, did not inhibit the IL-1 beta-induced protein synthesis or changes in mRNA levels. In ventricular myocardium obtained from adult rats treated with lipopolysaccharide (4 mg/kg intraperitoneally 18 h) to stimulate systemic cytokine production, there were changes in the mRNA levels for beta-MHC (6 +/- 1-fold, P < 0.01, n = 4), SERCA2 (-65 +/- 4%, P < 0.0001, n = 4), CRC (-67 +/- 5%, P < 0.001, n = 4), and VDCC (-58 +/- 5%, P < 0.001; n = 4) that were qualitatively similar to those observed in cultured myocytes. Thus, IL-1 beta, acting via an NO-independent mechanism, caused myocyte hypertrophy associated with induction of fetal genes (ANF and beta-MHC) and downregulation of three important calcium regulatory genes (SERCA2, CRC, and VDCC). IL-1 beta may contribute to the abnormal structural and functional alterations of cardiac myocytes in conditions marked by mononuclear cell infiltration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635944      PMCID: PMC185298          DOI: 10.1172/JCI118095

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium.

Authors:  R Schulz; E Nava; S Moncada
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

Review 2.  Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction.

Authors:  J P Morgan
Journal:  N Engl J Med       Date:  1991-08-29       Impact factor: 91.245

3.  Differential regulation of skeletal alpha-actin transcription in cardiac muscle by two fibroblast growth factors.

Authors:  T G Parker; K L Chow; R J Schwartz; M D Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression.

Authors:  T R Ulich; K Z Guo; B Irwin; D G Remick; G N Davatelis
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

5.  A growth factor for cardiac myocytes is produced by cardiac nonmyocytes.

Authors:  C S Long; C J Henrich; P C Simpson
Journal:  Cell Regul       Date:  1991-12

6.  Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure.

Authors:  T Takahashi; P D Allen; R V Lacro; A R Marks; A R Dennis; F J Schoen; W Grossman; J D Marsh; S Izumo
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function.

Authors:  S R Jones; A Herskowitz; G M Hutchins; K L Baughman
Journal:  Am J Cardiol       Date:  1991-08-01       Impact factor: 2.778

8.  Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy.

Authors:  A M Brillantes; P Allen; T Takahashi; S Izumo; A R Marks
Journal:  Circ Res       Date:  1992-07       Impact factor: 17.367

9.  Ca(2+)-ATPase and function of sarcoplasmic reticulum during cardiac hypertrophy.

Authors:  D Levitsky; D de la Bastie; K Schwartz; A M Lompré
Journal:  Am J Physiol       Date:  1991-10

10.  Detection of interleukin and interleukin-receptor mRNA in human heart by polymerase chain reaction.

Authors:  R O Han; P E Ray; K L Baughman; A M Feldman
Journal:  Biochem Biophys Res Commun       Date:  1991-12-16       Impact factor: 3.575

View more
  53 in total

Review 1.  Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.

Authors:  K Yamauchi-Takihara; T Kishimoto
Journal:  Int J Exp Pathol       Date:  2000-02       Impact factor: 1.925

Review 2.  Activation of cytokines as a mechanism of disease progression in heart failure.

Authors:  B Bozkurt
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 3.  Molecular and cellular mechanisms of myocardial remodeling.

Authors:  Melanie Maytin; Wilson S Colucci
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

4.  Pathways involved in interleukin-1β-mediated murine cardiomyocyte apoptosis.

Authors:  Yi Shen; Jie Qin; Peili Bu
Journal:  Tex Heart Inst J       Date:  2015-04-01

Review 5.  Immune modulation in heart failure: past challenges and future hopes.

Authors:  Jose H Flores-Arredondo; Gerardo García-Rivas; Guillermo Torre-Amione
Journal:  Curr Heart Fail Rep       Date:  2011-03

6.  Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes.

Authors:  J D Luo; F Xie; W W Zhang; X D Ma; J X Guan; X Chen
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

7.  Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.

Authors:  A Calderone; C M Thaik; N Takahashi; D L Chang; W S Colucci
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

8.  Interleukin-1β reduces L-type Ca2+ current through protein kinase Cϵ activation in mouse heart.

Authors:  Nabil El Khoury; Sophie Mathieu; Céline Fiset
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

9.  Original Research: Atorvastatin prevents rat cardiomyocyte hypertrophy induced by parathyroid hormone 1-34 associated with the Ras-ERK signaling.

Authors:  Xiaogang Liu; Chunbo Zou; Chengyuan Yu; Rujuan Xie; Manshu Sui; Suhong Mu; Li Li; Shilei Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

10.  Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction.

Authors:  Rochus Witthaut; Christian Busch; Peter Fraunberger; Autar Walli; Dietrich Seidel; Günter Pilz; Ralph Stuttmann; Norbert Speichermann; Ljifane Verner; Karl Werdan
Journal:  Intensive Care Med       Date:  2003-08-12       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.